Aa
Interesting Article in Today's Paper
http://wire.jacksonville.com/pstories/health/20090816/482391318.shtml
This is what I love to hear. Even though we sometimes feel HVC doesn't get much attention...research is being done. Each new discovery is bring us one step closer.......
This is what I love to hear. Even though we sometimes feel HVC doesn't get much attention...research is being done. Each new discovery is bring us one step closer.......
I only have one word to say about spelling: breath/breathe
Ok, so I can't count, either ;)
Gene research is going to be so important (imho) If they could locate this particular gene, then in time, I hope they can locate one that can predict response to therapy and from there taylor tx for those without the gene, tweaking tx so it works better for non-responders/relapsers.
Ok, so I can't count, either ;)
Gene research is going to be so important (imho) If they could locate this particular gene, then in time, I hope they can locate one that can predict response to therapy and from there taylor tx for those without the gene, tweaking tx so it works better for non-responders/relapsers.
What matters is that you get your point across. People who spend too much time checking everyone elses spelling, I have named the grammer police. I can't spell anyway, maybe thats why I don't care.
I wonder if this is going to change the studies? I mean they will surely have to test the patients first so is the sole reason people are non responders. I'm going August 27 for an appointment with a research nurse for a possible study. I guess I'll hear what they have to say. This finding seems like it could change allot of things.
M
M
No time to tell the terrible joke but the punchline is........
"If I'm going to BE IMPOTENT and going to *dress* impotent."
You'll have to imagine the rest......
willy ; )
"If I'm going to BE IMPOTENT and going to *dress* impotent."
You'll have to imagine the rest......
willy ; )
You guys are TOO lovable!
Love y'all,
Marcia
(you must admit that it looks mighty stupid to capitalize a word and to misspell it... it's really like shouting out 'I'm stupid!') well, maybe I am...
Love y'all,
Marcia
(you must admit that it looks mighty stupid to capitalize a word and to misspell it... it's really like shouting out 'I'm stupid!') well, maybe I am...
LOL, Marcia; it’s OK… it’s the only word you’ve misspelled in a year and a half. Oh, and it's not your first language either. You should see the typos I make in Dutch and Indonesian :o)!
Bill
Bill
Thanks Izzy, very interesting and INPORTANT. I wonder which gene I inherited, being half European half Afro-American
I'm just gonna paste it here, as it is so short.
Gene variant predicts hepatitis treatment success
MALCOLM RITTER
AP Science Writer
NEW YORK — Scientists say they've found a big reason why treatment for chronic hepatitis C infection works better for white patients than for African-Americans. It's a tiny variation in a gene.
People with a certain gene variant are far more likely to respond to treatment, and that variant is more common in people with European ancestry than African-Americans, researchers report.
In fact, that probably explains about half the racial disparity in treatment response, the scientists estimate in a study published online Sunday by the journal Nature.
The work involved 1,137 patients who had a chronic infection with the most common type of hepatitis C virus found in the United States and Europe, one that is is less responsive to treatment than other types. They were given standard **************.
Analysis showed the treatment wiped out the virus in about 80 percent of study participants with the favorable genetic variant, compared to only about 30 percent among those who lacked it.
African-Americans who had the gene variant showed a better response rate than whites who didn't have it, indicating that the gene is a better predictor than ethnicity, the researchers said.
Standard treatment for chronic hepatitis C takes months and has such potential side effects as flu-like symptoms and depression. So in deciding whether to treat, patients and doctors might be helped by testing for the variant first, say the study authors, from Duke University and elsewhere.
An estimated 170 million people around the world and perhaps 3.2 million people in the United States alone have a chronic hepatitis C infection. That puts them at risk for developing liver cirrhosis and cancer. The virus is spread by contact with infected blood, such as from using inadequately sterilized needles.
I'm just gonna paste it here, as it is so short.
Gene variant predicts hepatitis treatment success
MALCOLM RITTER
AP Science Writer
NEW YORK — Scientists say they've found a big reason why treatment for chronic hepatitis C infection works better for white patients than for African-Americans. It's a tiny variation in a gene.
People with a certain gene variant are far more likely to respond to treatment, and that variant is more common in people with European ancestry than African-Americans, researchers report.
In fact, that probably explains about half the racial disparity in treatment response, the scientists estimate in a study published online Sunday by the journal Nature.
The work involved 1,137 patients who had a chronic infection with the most common type of hepatitis C virus found in the United States and Europe, one that is is less responsive to treatment than other types. They were given standard **************.
Analysis showed the treatment wiped out the virus in about 80 percent of study participants with the favorable genetic variant, compared to only about 30 percent among those who lacked it.
African-Americans who had the gene variant showed a better response rate than whites who didn't have it, indicating that the gene is a better predictor than ethnicity, the researchers said.
Standard treatment for chronic hepatitis C takes months and has such potential side effects as flu-like symptoms and depression. So in deciding whether to treat, patients and doctors might be helped by testing for the variant first, say the study authors, from Duke University and elsewhere.
An estimated 170 million people around the world and perhaps 3.2 million people in the United States alone have a chronic hepatitis C infection. That puts them at risk for developing liver cirrhosis and cancer. The virus is spread by contact with infected blood, such as from using inadequately sterilized needles.
Always good news when you see research being done. I wish they wouldn't down-play the sx's "such potential side effects as flu-like symptoms and depression."
On 2nd thought maybe they do it as not to scare off any potential patients.
On 2nd thought maybe they do it as not to scare off any potential patients.
Have an Answer?
You are reading content posted in the Hepatitis C Community
Learn about this treatable virus.
Getting tested for this viral infection.
3 key steps to getting on treatment.
4 steps to getting on therapy.
What you need to know about Hep C drugs.
How the drugs might affect you.
These tips may up your chances of a cure.
A list of national and international resources and hotlines to help connect you to needed health and medical services.
Herpes sores blister, then burst, scab and heal.
Herpes spreads by oral, vaginal and anal sex.
STIs are the most common cause of genital sores.
Condoms are the most effective way to prevent HIV and STDs.
PrEP is used by people with high risk to prevent HIV infection.
